Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Mid-range Performer
1996.0000
-12.20
(
-0.61
%)
NSE
Jan 19, 2026
09:07 AM
56.49% Gain from 52W Low
Volume:
309
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
18 Jun 2024
1996.00
-0.61%
GLENMARK PHARMACEUTICALS
Hold:
Glenmark Pharmaceuticals Ltd.
by
Geojit BNP Paribas
Target: 1319
Target
Geojit BNP Paribas
Glenmark Pharmaceuticals Ltd. is trading
below its 30 day SMA
of 2003.3
More from Glenmark Pharmaceuticals Ltd.
Recommended
Market closes lower, dragged down by foreign investor outflows and mixed earnings
Trendlyne Marketwatch |
13 Jan 2026
IPO wave continues as Amagi Media and Five SMEs open for subscription
|
12 Jan 2026
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020